摘要
支气管哮喘是一种常见的慢性呼吸道疾病,其免疫发病机制尚不十分清楚。CD4+CD25+调节性T细胞是一种特殊的调节性T细胞,参与自身免疫调节,维持自身免疫耐受。本文就CD4+CD25+调节性T细胞的特性及与支气管哮喘的发病机制、治疗、预后的研究进展做一综述。
Asthma is a frequent chronic respiratory, disease, whose immunological pathogenesis is not clear completely. CD4^+ CD25^+ regulatory T cell is a special kind of regulatory T cells, which participates in autoimmune regulation and maintains immunological tolerance. The review summarized the characters of CD4^+ CD25^+ regulatory T cell and its roles in the mechanism of pathogenesis, therapy and prognosis of asthma.
出处
《国际内科学杂志》
CAS
2008年第1期37-40,共4页
International Journal of Internal Medicine